Buprenorphine and Naloxone
Buprenorphine and Naloxone is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Buprenorphine and Naloxone; Generic name: BUPRENORPHINE AND NALOXONE; Manufacturer: REMEDYREPACK INC..
| Brand name | Buprenorphine and Naloxone |
|---|---|
| Generic name | BUPRENORPHINE AND NALOXONE |
| Manufacturer | REMEDYREPACK INC. |
| Used for | 1 INDICATIONS AND USAGE Buprenorphine and naloxone sublingual tablets are indicated for maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. Buprenorphine and naloxone sublingual tablets contain buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for the maintenance treatment of opioid dependence. ( 1 ) Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION Administer buprenorphine and naloxone sublingual tablet sublingually as a single daily dose. ( 2.1 ) Strongly consider recommending or prescribing an opioid overdose reversal agent (e.g., naloxone, nalmefene) at the time buprenorphine and naloxone sublingual tablet are initiated or renewed because patients being treated for opioid use disorder have the potential for relapse, putting them at risk for opioid overdose. ( 2.2 ) To avoid precipitating withdrawal, induction |
| Active ingredient(s) | BUPRENORPHINE HYDROCHLORIDE |
| Route | SUBLINGUAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=072b2c2e-a564-4bb4-8954-9349a7923807 |